About Alsachim
Alsachim is a Healthcare company based in Illkirch-graffenstaden (France) founded in 2005 by Jean-Francois Hoeffler, and was acquired by Shimadzu Corporation in June 2017. Custom synthesis of stable radioisotopes analytical services for pharmaceutical and biotech companies. Its chief executive, as recorded, is Jean-Francois Hoeffler. Alsachim offers products and services including Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Radioisotopes.
Company details
Alsachim was founded in 2005 and is based in Illkirch Graffenstaden, France. Operations focus on the pharmaceutical and biotechnology industries, where custom synthesis of stable isotopically labeled molecules is conducted, including intermediates, reference standards, metabolites, peptides, and biologically active compounds. Analytical services, such as HPLC, mass spectrometry, and NMR analysis, are also offered to support research and development needs in these sectors.
- Headquarters Illkirch-graffenstaden, France
- Founders Jean-Francois Hoeffler
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website alsachim.com
- Social LinkedIn X Facebook
- Acquired by Shimadzu Corporation (Jun 2017)
- InvestorsShimadzu Corporation
& 1 more
- Acquired byShimadzu Corporation
(Jun 2017)
Products & Services of Alsachim
Alsachim offers a comprehensive portfolio of products and services, including Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis.
Standards for precise laboratory analysis and testing
Products for accurate chemical reference in diagnostics
Kits like DOSIMMUNE for specific clinical applications
Tailored synthesis services for research needs
Funding Insights of Alsachim
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Alsachim with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2006 | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Alsachim
Alsachim has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Shimadzu Corporation and Naxicap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in small and medium-sized businesses are managed by Naxicap. | naxicap.com | Frankfurt Am Main, Germany | ||
Medical imaging systems, industrial machinery, and analytical instruments are provided. | 1875 | shimadzu.com | Tokyo, Japan |
Investor details for Alsachim
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Alsachim
1 people are tracked at Alsachim (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jean-Francois Hoeffler | Founder & CEO | Leadership |
Complete people profiles for Alsachim
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Alsachim
3 dated milestones of Alsachim across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Alsachim is founded.
- Funding First funding round.
- Exit Acquired by Shimadzu Corporation.
Web traffic of Alsachim
The website of Alsachim (alsachim.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 14.1% vs previous month
Websites whose visitors overlap most with Alsachim. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medicalisotopes.com | medicalisotopes.com | 100% | – | ||
iso-analytical.co.uk | iso-analytical.co.uk | 85% | – | ||
instrumentscience.com | instrumentscience.com | 84% | – | ||
materialinterface.com | materialinterface.com | 83% | #12,290,420 | – | |
las.perkinelmer.com | las.perkinelmer.com | 83% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Alsachim
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alsachim
Alsachim was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Alsachim is headquartered in Illkirch-graffenstaden, France. It is registered at Illkirch-graffenstaden, Bas-rhin, France.
Jean-Francois Hoeffler is the CEO of Alsachim, as recorded in our data. They have also founded this company.
Alsachim was founded in 2005 and is based in Illkirch Graffenstaden, France. Operations focus on the pharmaceutical and biotechnology industries, where custom synthesis of stable isotopically labeled molecules is conducted, including intermediates, reference standards, metabolites, peptides, and biologically active compounds. Analytical services, such as HPLC, mass spectrometry, and NMR analysis, are also offered to support research and development needs in these sectors.
Alsachim offers Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis.
Alsachim has 2 investors. Key investors include Shimadzu Corporation, and Naxicap.
Yes. Alsachim was acquired by Shimadzu Corporation in June 2017.